| |
RG+A Hires Two Directors
In the US, healthcare research specialist Roger Green and Associates (RG+A) has appointed Jennifer Seiberlich Brown and Barry Davis as Directors.
Seiberlich Brown joins from biotech firm AMGEN, where she was most recently Market Research Manager, Business Analysis and Information in the firm's Oncology Business Unit. Prior to this, she spent more than six years at GlaxoSmithKline Pharmaceuticals, and worked as Sales Manager, Direct Marketing for the Las Vegas Thunder Hockey Team. She has a BS in Marketing from the Pennsylvania State University.
Davis joins the firm's Qualitative Research Practice, bringing more than twenty years of experience in the pharma, marketing research and financial services industries. He most recently worked for TVG Marketing Research as Executive Director (www.mrweb.com/movers/app52.htm ), before which, he was a Qualitative Research Consultant and spent several years working in marketing analysis and financial planning for SmithKline Beecham Pharmaceuticals, Colonial Penn and Coopers and Lybrand. He has a BS in Business from Northeastern University in Boston.
President and CEO Roger Green noted: 'The addition of both Jennifer and Barry continues our growth strategy and further enhances our ability to provide the strategic insight that our clients have grown to expect from us.'
Last summer, as part of a restructure, the firm appointed Andrew Ginsberg as EVP responsible for the firm's Qual Practice and its Research / Analytics Group, and Bruce Duncan as Chief Research Officer charged with training and mentoring the company's researchers (www.mrweb.com/drno/news7031.htm ).
RG+A is headquartered in New Hope, Pennsylvania, and works for pharmaceutical, biotech and medical device companies in the US and internationally, on projects including new product development, position, pricing, market valuation and impact modeling. The firm is online at www.rogergreen.com.
|
